Active NCI RFAs:  FY 2021  FY 2020  FY 2019 | Archive RFAs | Active PAs
Current and Recent Requests for Applications (RFA's)
RFA's that are active or have expired within the last 3 months (and associated notices)
 
2021 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA21-037 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)ACTIVE - NOV 23, 2021
CA21-036 SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)ACTIVE - AUG 07, 2021
CA21-035 The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)ACTIVE - SEP 10, 2021
CA21-034 The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed)ACTIVE - SEP 10, 2021
CA21-033 The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional)ACTIVE - SEP 10, 2021
CA21-032 Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed)ACTIVE - JUL 15, 2021
CA21-031 Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required)ACTIVE - JUL 15, 2021
CA21-030 Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)EXPIRED - JUN 03, 2021
CA21-029 Centers on Telehealth Research for Cancer Related Care (P50 Clinical Trial Required)ACTIVE - JUL 21, 2021
CA21-025 Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed)ACTIVE - JUL 31, 2021
CA21-024 Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)ACTIVE - JUL 01, 2021
CA21-023 Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)ACTIVE - JUL 01, 2021
CA21-019 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)ACTIVE - NOV 19, 2021
CA21-018 Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)ACTIVE - NOV 18, 2021
CA21-017 Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)ACTIVE - NOV 18, 2021
CA21-016 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-015 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-014 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-013 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)ACTIVE - NOV 18, 2021
CA21-012 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-011 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-010 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-009 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-008 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-007 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)ACTIVE - SEP 30, 2021
CA21-006 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)ACTIVE - SEP 30, 2021
CA21-005 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)ACTIVE - SEP 30, 2021
CA21-004 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)ACTIVE - SEP 29, 2021
CA21-003 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)ACTIVE - SEP 30, 2021
CA21-001 Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)EXPIRED - MAR 25, 2021
 
2021 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
MD21-004 Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)ACTIVE - AUG 25, 2021
OD21-009 Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)ACTIVE - JUL 08, 2021
OD21-008 Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional)ACTIVE - JUL 08, 2021
OD21-006 Building Interdisciplinary Research Careers in Women's Health Program (BIRCWH) (K12 Clinical Trial Optional)EXPIRED - JUN 12, 2021
OD21-005 Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed)EXPIRED - JUN 05, 2021
OD21-004 Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)ACTIVE - MAR 09, 2023
OD21-003 Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)ACTIVE - MAR 09, 2023
OD21-002 Tobacco Regulatory Science (R01 Clinical Trial Optional)ACTIVE - FEB 15, 2023
RM21-010 Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed)EXPIRED - MAR 23, 2021
RM21-004 Nutrition for Precision Health, powered by the All of Us Research Program: Dietary Assessment Center (U24 Clinical Trial Optional)EXPIRED - APR 07, 2021
RM21-002 Nutrition for Precision Health, powered by the All of Us Research Program: Metabolomics and Clinical Assays Center (U24 Clinical Trial Not Allowed)EXPIRED - APR 07, 2021
RM21-001 Nutrition for Precision Health, powered by the All of Us Research Program: Artificial Intelligence for Multimodal Data Modeling and Bioinformatics Center (U54 Clinical Trial Not AllowedEXPIRED - APR 07, 2021
TW21-004 Launching Future Leaders in Global Health (LAUNCH) Research Training Program (D43 Clinical Trial Optional)ACTIVE - AUG 21, 2021
TW21-002 Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research Training (Collaborative U2R Clinical Trial Optional)ACTIVE - JUL 09, 2021
TW21-001 Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional)ACTIVE - JUL 09, 2021
 
 
 
 
2020 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA20-051 Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)ACTIVE - JAN 19, 2022
CA20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)ACTIVE - DEC 15, 2021
CA20-031 Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)ACTIVE - JUN 25, 2021
CA20-029 Metastasis Research Network (U54 Clinical Trial Not Allowed)EXPIRED - MAY 29, 2021
CA20-028 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)ACTIVE - JUL 31, 2021
CA20-027 Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)ACTIVE - JUL 31, 2021
 
2020 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
HG20-048 Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional)ACTIVE - JUL 09, 2021
HL20-006 Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)ACTIVE - JAN 15, 2022
NS20-011 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)ACTIVE - SEP 09, 2022
NS20-010 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)ACTIVE - SEP 09, 2022
NS20-009 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)ACTIVE - SEP 09, 2022
NS20-008 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)ACTIVE - SEP 09, 2022
OD20-011 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)ACTIVE - JUL 11, 2022
OD20-010 Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)ACTIVE - JUL 11, 2022
OD20-009 Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)ACTIVE - JUL 11, 2022
OD20-008 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)ACTIVE - JUL 11, 2022
 
 
 
 
2019 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA19-053 Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021
CA19-052 Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021
CA19-051 Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021
CA19-050 Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021
CA19-049 Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)ACTIVE - JUN 24, 2021